Lataa…
Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line
The aim of the present study was to investigate the ability of Nimotuzumab to increase radiosensitivity at different delivery times in the mixed cancer cell line Eca109, to determine the optimal delivery time. Cultured Eca109 cells were classified into five groups: Control with no treatment (O group...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Online Artikkeli Teksti |
| Kieli: | English |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365957/ https://www.ncbi.nlm.nih.gov/pubmed/30854050 http://dx.doi.org/10.3892/ol.2019.9897 |